These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24806316)

  • 1. Physicians should declare financial incentives for recruiting minority ethnic patients into clinical trials.
    Mainous AG
    BMJ; 2014 May; 348():g2985. PubMed ID: 24806316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of physician disclosure of financial incentives on trust.
    Levinson W; Kao A; Kuby AM; Thisted RA
    Arch Intern Med; 2005 Mar; 165(6):625-30. PubMed ID: 15795337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Trust of Turkish and Arabic ethnic minority patients in their Dutch oncologist].
    Hillen M; el Temna S; van der Vloodt J; de Haes H; Smets EM
    Ned Tijdschr Geneeskd; 2013; 157(16):A5881. PubMed ID: 23594873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A trial of disclosing physicians' financial incentives to patients.
    Pearson SD; Kleinman K; Rusinak D; Levinson W
    Arch Intern Med; 2006 Mar; 166(6):623-8. PubMed ID: 16567600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Just Good Developmental Science: Trust, Identity, and Responsibility in Ethnic Minority Recruitment and Retention.
    Rivas-Drake D; Camacho TC; Guillaume C
    Adv Child Dev Behav; 2016; 50():161-88. PubMed ID: 26956073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. US Nationwide Disclosure of Industry Payments and Public Trust in Physicians.
    Kanter GP; Carpenter D; Lehmann LS; Mello MM
    JAMA Netw Open; 2019 Apr; 2(4):e191947. PubMed ID: 30977850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider disclosure of financial incentives in managed care: pros and cons.
    McCormack R
    Bioethics Forum; 1996; 12(1):21-4. PubMed ID: 11654388
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethnic minority under-representation in clinical trials. Whose responsibility is it anyway?
    Hussain-Gambles M
    J Health Organ Manag; 2003; 17(2):138-43. PubMed ID: 12916177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic conflicts of interest in clinical research: a need for disclosure.
    Sollitto S; Hoffman S; Mehlman M; Lederman RJ; Youngner SJ; Lederman MM
    Kennedy Inst Ethics J; 2003 Jun; 13(2):83-91. PubMed ID: 14569995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trust in insurers and access to physicians: associated enrollee behaviors and changes over time.
    Balkrishnan R; Hall MA; Blackwelder S; Bradley D
    Health Serv Res; 2004 Aug; 39(4 Pt 1):813-23. PubMed ID: 15230929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for improving patients' trust in doctors and groups of doctors.
    Rolfe A; Cash-Gibson L; Car J; Sheikh A; McKinstry B
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD004134. PubMed ID: 24590693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How disclosing HMO physician incentives affects trust.
    Hall MA; Dugan E; Balkrishnan R; Bradley D
    Health Aff (Millwood); 2002; 21(2):197-206. PubMed ID: 11900159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparity in physician-patient communication by ethnicity: evidence from Bangladesh.
    Zakaria M; Karim R; Rahman M; Cheng F; Xu J
    Int J Equity Health; 2021 Feb; 20(1):65. PubMed ID: 33627120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient advocates or patient adversaries? Using fiduciary law to compel disclosure of managed care financial incentives.
    Johnston K
    San Diego Law Rev; 1998; 35(4):951-92. PubMed ID: 12778919
    [No Abstract]   [Full Text] [Related]  

  • 15. Breaking the learned helplessness of patients: why MCOs should be required to disclose finanial incentives.
    Talesh SA
    Law Psychol Rev; 2002; 26(1):49-95. PubMed ID: 16526104
    [No Abstract]   [Full Text] [Related]  

  • 16. Involving South Asian patients in clinical trials.
    Hussain-Gambles M; Leese B; Atkin K; Brown J; Mason S; Tovey P
    Health Technol Assess; 2004 Oct; 8(42):iii, 1-109. PubMed ID: 15488164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of EMPaCT and fundamental issues affecting minority participation in cancer clinical trials: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual.
    Vickers SM; Fouad MN
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1087-90. PubMed ID: 24643645
    [No Abstract]   [Full Text] [Related]  

  • 18. Trust, The fragile foundation of contemporary biomedical research.
    Kass NE; Sugarman J; Faden R; Schoch-Spana M
    Hastings Cent Rep; 1996; 26(5):25-9. PubMed ID: 8891706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disclosing physician financial incentives.
    Miller TE; Sage WM
    JAMA; 1999 Apr; 281(15):1424-30. PubMed ID: 10217059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in improving mental health services for racial-ethnic minority groups: a ten-year perspective.
    Santiago CD; Miranda J
    Psychiatr Serv; 2014 Feb; 65(2):180-5. PubMed ID: 24178249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.